Pulmonary Fibrosis Related to Amiodarone—Is It a Standard Pathophysiological Pattern? A Case-Based Literature Review

Amiodarone hydrochloride is an antiarrhythmic drug, with proven efficacy in prevention and treatment of numerous arrhythmias, atrial fibrillation especially, or ventricular arrhythmias, with a long half-life (55–60 days). The increased risk of developing amiodarone-induced pulmonary fibrosis is dire...

Descripción completa

Detalles Bibliográficos
Autores principales: Budin, Corina Eugenia, Cocuz, Iuliu Gabriel, Sabău, Adrian Horațiu, Niculescu, Raluca, Ianosi, Ingrid Renata, Ioan, Vladimir, Cotoi, Ovidiu Simion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777900/
https://www.ncbi.nlm.nih.gov/pubmed/36553223
http://dx.doi.org/10.3390/diagnostics12123217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777900/
https://www.ncbi.nlm.nih.gov/pubmed/36553223
http://dx.doi.org/10.3390/diagnostics12123217

Ejemplares similares